Anna Blom
101 – 110 of 325
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
(
- Contribution to journal › Article
-
Mark
Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer
(
- Contribution to journal › Article
-
Mark
The complement inhibitor factor H generates an anti-inflammatory and tolerogenic state in monocyte-derived dendritic cells
(
- Contribution to journal › Article
-
Mark
C4b-binding protein protects β-cells from islet amyloid polypeptide-induced cytotoxicity
(
- Contribution to journal › Article
-
Mark
Quantitative mass spectrometry to study inflammatory cartilage degradation and resulting interactions with the complement system
(
- Contribution to journal › Article
-
Mark
FACIN, a double-edged sword of the emerging periodontal pathogen filifactor alocis : A metabolic enzyme moonlighting as a complement inhibitor
(
- Contribution to journal › Article
-
Mark
Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes.
(
- Contribution to journal › Article
-
Mark
CD46 Activation Regulates miR-150-Mediated Control of GLUT1 Expression and Cytokine Secretion in Human CD4+ T Cells.
(
- Contribution to journal › Article
-
Mark
C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend.
(
- Contribution to journal › Scientific review
-
Mark
New perspectives on complement mediated immunotherapy
(
- Contribution to journal › Scientific review